(Reuters) – Common anti-inflammatory medicine aspirin will now tested as a possible treatment for COVID-19 in one of the biggest UK trials looking into a range of potential treatments against the illness, the RECOVERY trial website said on Friday.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)

